OXBOF Stock - Oxford BioDynamics Plc
Unlock GoAI Insights for OXBOF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.09M | $636,000 | $510,000 | $154,000 | $341,000 |
| Gross Profit | $-8,265,485 | $289,000 | $266,000 | $116,000 | $341,000 |
| Gross Margin | -754.8% | 45.4% | 52.2% | 75.3% | 100.0% |
| Operating Income | $-11,074,000 | $-12,894,000 | $-10,168,000 | $-8,601,000 | $-7,512,000 |
| Net Income | $-14,991,862 | $-11,567,000 | $-10,826,000 | $-6,710,000 | $-6,682,000 |
| Net Margin | -1369.1% | -1818.7% | -2122.7% | -4357.1% | -1959.5% |
| EPS | $-0.01 | $-0.04 | $-0.07 | $-0.07 | $-0.07 |
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Visit WebsiteEarnings History & Surprises
OXBOFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Dec 16, 2025 | — | — | — | — |
Q2 2025 | Jun 30, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 28, 2025 | — | $-0.04 | — | — |
Q2 2024 | Jun 18, 2024 | — | $-0.03 | — | — |
Q1 2024 | Mar 27, 2024 | — | $-0.05 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.04 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.04 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.04 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.05 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.05 | — | — |
Q1 2021 | Jan 28, 2021 | — | $-0.03 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.03 | — | — |
Q1 2020 | Jan 23, 2020 | — | $-0.02 | — | — |
Q2 2019 | May 28, 2019 | — | $-0.02 | — | — |
Q4 2018 | Dec 11, 2018 | — | $-0.01 | — | — |
Q2 2018 | May 22, 2018 | — | $-0.02 | — | — |
Q1 2018 | Jan 30, 2018 | — | $-0.02 | — | — |
Q2 2017 | Jun 13, 2017 | — | $-0.04 | — | — |
Q1 2017 | Jan 31, 2017 | — | $-0.01 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about OXBOF
What is OXBOF's current stock price?
What is the analyst price target for OXBOF?
What sector is Oxford BioDynamics Plc in?
What is OXBOF's market cap?
Does OXBOF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to OXBOF for comparison